InsightfulValue
← Home

Coloplast
Coloplast

-5.92%

Healthcare & biotech / Medical devices and services


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (2)
Coloplast

πŸ“Š Get full analytics about Coloplast

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Overview
Coloplast is a Danish medical device company that specializes in the development and production of products for the management of various health conditions, including ostomy, continence, wound care, skin health, and urology. The company was founded in 1957 and is headquartered in Humlebæk, Denmark.
Coloplast's mission is to make life easier for people with health conditions by providing innovative and high-quality products that improve their quality of life. The company has a strong focus on research and development, with a team of scientists and engineers constantly working to improve their product offerings.
Coloplast has a global presence, with operations in over 50 countries and distribution in more than 100 countries. The company has approximately 12,000 employees worldwide and reported revenue of DKK 17.842 billion in 2020.
Products of Coloplast
Coloplast offers a wide range of products for ostomy, continence, wound care, skin health, and urology. Some of their most well-known products include:
1. SenSura Mio: A one-piece ostomy pouch system that is designed to fit individual body shapes and provide a secure and comfortable fit.
2. SpeediCath: A ready-to-use intermittent catheter for people with bladder problems, aiming to reduce the risk of urinary tract infections.
3. Biatain: A range of wound dressings that absorb excess wound fluid and provide a moist healing environment.
4. Brava Skin Barrier: A range of skin barrier products designed to protect the skin around a stoma and prevent skin irritation.
5. Conveen: A range of products for managing male urinary incontinence, including external catheters and leg bags.
6. Peristeen: A rectal irrigation system for people with bowel problems, aiming to improve bowel function and reduce the risk of constipation.
7. Arion: A range of skin care products for people with incontinence, designed to protect and soothe the skin.
8. SpeediBag: A range of sterile urine bags for people with bladder problems, designed to be discreet and easy to use.
Overall, Coloplast focuses on providing innovative products that are easy to use, comfortable, and promote better health and quality of life for their customers.
What is special about the company?
Coloplast

πŸ“ˆ Want to read more about Coloplast?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

MS4gRm9jdX Mgb24gbWVk aWNhbCBkZX ZpY2VzIGFu ZCBzZXJ2aW NlczogQ29s b3BsYXN0IG lzIGEgZ2xv YmFsIGxlYW RlciBpbiB0 aGUgZGV2ZW xvcG1lbnQg YW5kIHByb2 R1Y3Rpb24g b2YgbWVkaW NhbCBkZXZp Y2VzIGFuZC BzZXJ2aWNl cywgc3BlY2 lmaWNhbGx5 IGluIHRoZS BhcmVhcyBv ZiBvc3RvbX ksIHVyb2xv Z3ksIGNvbn RpbmVuY2Us IGFuZCB3b3 VuZCBjYXJl LiBUaGlzIG ZvY3VzIGFs bG93cyB0aG UgY29tcGFu eSB0byBoYX ZlIGEgZGVl cCB1bmRlcn N0YW5kaW5n IG9mIHRoZS BzcGVjaWZp YyBuZWVkcy BhbmQgY2hh bGxlbmdlcy BmYWNlZCBi eSBwYXRpZW 50cyB3aXRo IHRoZXNlIG NvbmRpdGlv bnMgYW5kIG RldmVsb3Ag aW5ub3ZhdG l2ZSBzb2x1 dGlvbnMgdG 8gbWVldCB0 aG9zZSBuZW Vkcy48YnI+ Mi4gUGF0aW VudC1jZW50 cmljIGFwcH JvYWNoOiBD b2xvcGxhc3 QncyBtaXNz aW9uIGlzIH RvIG1ha2Ug bGlmZSBlYX NpZXIgZm9y IHBlb3BsZS B3aXRoIGlu dGltYXRlIG hlYWx0aGNh cmUgbmVlZH MuIFRoZSBj b21wYW55IH Rha2VzIGEg cGF0aWVudC 1jZW50cmlj IGFwcHJvYW NoIGluIGFs bCBhc3BlY3 RzIG9mIGl0 cyBidXNpbm VzcywgZnJv bSBwcm9kdW N0IGRldmVs b3BtZW50IH RvIGN1c3Rv bWVyIHNlcn ZpY2UsIHRv IGVuc3VyZS B0aGUgYmVz dCBwb3NzaW JsZSBjYXJl IGFuZCBvdX Rjb21lcyBm b3IgcGF0aW VudHMuPGJy PjMuIENvbG xhYm9yYXRp dmUgcGFydG 5lcnNoaXBz OiBDb2xvcG xhc3QgY29s bGFib3JhdG VzIHdpdGgg aGVhbHRoY2 FyZSBwcm9m ZXNzaW9uYW xzLCBwYXRp ZW50IG9yZ2 FuaXphdGlv bnMsIGFuZC BvdGhlciBz dGFrZWhvbG RlcnMgdG8g dW5kZXJzdG FuZCB0aGUg bmVlZHMgb2 YgcGF0aWVu dHMgYW5kIG RldmVsb3Ag cHJvZHVjdH MgYW5kIHNl cnZpY2VzIH RoYXQgYWRk cmVzcyB0aG VtLiBUaGlz IGNvbGxhYm 9yYXRpdmUg YXBwcm9hY2 ggZm9zdGVy cyBpbm5vdm F0aW9uIGFu ZCBlbnN1cm VzIHRoYXQg Q29sb3BsYX N0J3Mgc29s dXRpb25zIG FyZSBlZmZl Y3RpdmUgYW 5kIHJlbGV2 YW50Ljxicj 40LiBHbG9i YWwgcHJlc2 VuY2U6IFdp dGggb3Blcm F0aW9ucyBp biBvdmVyID UwIGNvdW50 cmllcyBhbm QgcHJvZHVj dHMgc29sZC BpbiBtb3Jl IHRoYW4gMT AwIGNvdW50 cmllcywgQ2 9sb3BsYXN0 IGhhcyBhIH N0cm9uZyBn bG9iYWwgcH Jlc2VuY2Uu IFRoaXMgYW xsb3dzIHRo ZSBjb21wYW 55IHRvIHJl YWNoIGFuZC BzZXJ2ZSBh IGRpdmVyc2 UgcmFuZ2Ug b2YgcGF0aW VudHMgd29y bGR3aWRlLC BtYWtpbmcg aXQgYSBsZW FkZXIgaW4g dGhlIGludG VybmF0aW9u YWwgaGVhbH RoY2FyZSBp bmR1c3RyeS 48YnI+NS4g U3Ryb25nIG NvbW1pdG1l bnQgdG8gc3 VzdGFpbmFi aWxpdHk6IE NvbG9wbGFz dCBpcyBjb2 1taXR0ZWQg dG8gb3Blcm F0aW5nIHN1 c3RhaW5hYm x5LCBib3Ro IGluIHRlcm 1zIG9mIGl0 cyBlbnZpcm 9ubWVudGFs IGltcGFjdC BhbmQgaXRz IHNvY2lhbC ByZXNwb25z aWJpbGl0eS 4gVGhlIGNv bXBhbnkgaG FzIHNldCBh bWJpdGlvdX MgZ29hbHMg dG8gcmVkdW NlIGl0cyBj YXJib24gZW 1pc3Npb25z LCB3YXRlci Bjb25zdW1w dGlvbiwgYW 5kIHdhc3Rl LCBhcyB3ZW xsIGFzIGlt cHJvdmUgZX RoaWNhbCBw cmFjdGljZX MgdGhyb3Vn aG91dCBpdH Mgc3VwcGx5 IGNoYWluLj xicj42LiBD dWx0dXJlIG 9mIGlubm92 YXRpb246IE NvbG9wbGFz dCBoYXMgYS BzdHJvbmcg Y3VsdHVyZS BvZiBpbm5v dmF0aW9uLC BmdWVsZWQg YnkgaXRzIG RlZGljYXRl ZCB0ZWFtcy BvZiByZXNl YXJjaGVycy BhbmQgZW5n aW5lZXJzLi BUaGUgY29t cGFueSBpbn Zlc3RzIGhl YXZpbHkgaW 4gcmVzZWFy Y2ggYW5kIG RldmVsb3Bt ZW50LCBjb2 5zdGFudGx5 IHNlZWtpbm cgbmV3IGFu ZCBiZXR0ZX Igd2F5cyB0 byBhZGRyZX NzIHRoZSBu ZWVkcyBvZi BwYXRpZW50 cyBhbmQgaW 1wcm92ZSB0 aGVpciBxdW FsaXR5IG9m IGxpZmUuPG JyPjcuIENv cnBvcmF0ZS Bnb3Zlcm5h bmNlIGFuZC ByZXNwb25z aWJpbGl0eT ogQ29sb3Bs YXN0IGhhcy BhIHN0cm9u ZyBmb2N1cy BvbiByZXNw b25zaWJsZS Bjb3Jwb3Jh dGUgZ292ZX JuYW5jZSBh bmQgZXRoaW NhbCBiZWhh dmlvci4gVG hpcyBpbmNs dWRlcyBhcm VhcyBzdWNo IGFzIGNvbX BsaWFuY2Us IHRyYW5zcG FyZW5jeSwg YW5kIGFjY2 91bnRhYmls aXR5LCBhcy B3ZWxsIGFz IGV0aGljYW wgbWFya2V0 aW5nIGFuZC BzYWxlcyBw cmFjdGljZX MuPGJyPjgu IEVtcGxveW VlIGRldmVs b3BtZW50IG FuZCBkaXZl cnNpdHk6IE NvbG9wbGFz dCB2YWx1ZX MgZGl2ZXJz aXR5IGFuZC BpbnZlc3Rz IGluIGl0cy BlbXBsb3ll ZXMnIGRldm Vsb3BtZW50 IGFuZCB3ZW xsLWJlaW5n LiBUaGUgY2 9tcGFueSBv ZmZlcnMgYS B2YXJpZXR5 IG9mIHRyYW luaW5nIGFu ZCBkZXZlbG 9wbWVudCBw cm9ncmFtcy wgYXMgd2Vs bCBhcyBoZW FsdGggYW5k IHdlbGxuZX NzIGluaXRp YXRpdmVzLC B0byBzdXBw b3J0IGl0cy BlbXBsb3ll ZXMnIHBlcn NvbmFsIGFu ZCBwcm9mZX NzaW9uYWwg Z3Jvd3RoLj xicj45LiBB d2FyZHMgYW 5kIHJlY29n bml0aW9uOi BDb2xvcGxh c3QgaGFzIG JlZW4gcmVj b2duaXplZC Bmb3IgaXRz IGV4Y2VsbG VuY2UgaW4g dmFyaW91cy BhcmVhcywg aW5jbHVkaW 5nIHByb2R1 Y3QgaW5ub3 ZhdGlvbiwg c3VzdGFpbm FiaWxpdHks IGFuZCBjb3 Jwb3JhdGUg cmVzcG9uc2 liaWxpdHku IFNvbWUgb2 YgdGhlIGNv bXBhbnkncy Btb3N0IG5v dGFibGUgYX dhcmRzIGlu Y2x1ZGUgRm 9yYmVzJyBN b3N0IElubm 92YXRpdmUg R3Jvd3RoIE NvbXBhbmll cyBhbmQgQ2 9ycG9yYXRl IEtuaWdodH MnIEdsb2Jh bCAxMDAgTW 9zdCBTdXN0 YWluYWJsZS BDb3Jwb3Jh dGlvbnMuPG JyPjEwLiBD b21taXRtZW 50IHRvIG1h a2luZyBhIH Bvc2l0aXZl IGltcGFjdD ogQWJvdmUg YWxsLCBDb2 xvcGxhc3Qg aXMgYSBjb2 1wYW55IHRo YXQgaXMgY2 9tbWl0dGVk IHRvIG1ha2 luZyBhIHBv c2l0aXZlIG ltcGFjdCBp biB0aGUgd2 9ybGQgYW5k IGltcHJvdm luZyB0aGUg bGl2ZXMgb2 YgcGF0aWVu dHMuIFRoaX MgY29yZSB2 YWx1ZSBkcm l2ZXMgdGhl IGNvbXBhbn kncyBhY3Rp b25zIGFuZC BkZWNpc2lv bnMsIG1ha2 luZyBpdCBh IHNwZWNpYW wgYW5kIHJl cHV0YWJsZS Bvcmdhbml6 YXRpb24u
What the company's business model?
Coloplast

πŸ“ˆ Want to read more about Coloplast?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIENvbG 9wbGFzdCBj b21wYW55J3 MgYnVzaW5l c3MgbW9kZW wgaXMgYnVp bHQgb24gdG hyZWUgcGls bGFyczogSW 5ub3ZhdGlv biwgY3VzdG 9tZXIgZm9j dXMsIGFuZC BzdXN0YWlu YWJpbGl0eS 4gVGhleSBz cGVjaWFsaX plIGluIGRl c2lnbmluZy wgbWFudWZh Y3R1cmluZy wgYW5kIGRp c3RyaWJ1dG luZyBtZWRp Y2FsIGRldm ljZXMgYW5k IHNlcnZpY2 VzIGZvciBw ZW9wbGUgd2 l0aCBpbnRp bWF0ZSBoZW FsdGhjYXJl IG5lZWRzLi BUaGVpciBi dXNpbmVzcy Btb2RlbCBm b2N1c2VzIG 9uIGRldmVs b3BpbmcgaW 5ub3ZhdGl2 ZSBzb2x1dG lvbnMgaW4g dXJvbG9neS wgY29udGlu ZW5jZSwgYW 5kIHdvdW5k IGNhcmUgdG 8gaW1wcm92 ZSB0aGUgcX VhbGl0eSBv ZiBsaWZlIG ZvciB0aGVp ciBjdXN0b2 1lcnMuIFRo ZXkgYWxzby BzdHJpdmUg dG8gbWFpbn RhaW4gYSBz dHJvbmcgY3 VzdG9tZXIg Zm9jdXMgYn kgY29sbGFi b3JhdGluZy B3aXRoIGhl YWx0aGNhcm UgcHJvZmVz c2lvbmFscy BhbmQgZW5n YWdpbmcgd2 l0aCB0aGVp ciBjdXN0b2 1lcnMgdG8g dW5kZXJzdG FuZCB0aGVp ciBuZWVkcy BhbmQgcHJv dmlkZSBwZX Jzb25hbGl6 ZWQgc29sdX Rpb25zLiBB ZGRpdGlvbm FsbHksIHN1 c3RhaW5hYm lsaXR5IGlz IGEga2V5IG NvbXBvbmVu dCBvZiB0aG VpciBidXNp bmVzcyBtb2 RlbCwgZW1w aGFzaXppbm cgcmVzcG9u c2libGUgYW 5kIGV0aGlj YWwgcHJhY3 RpY2VzIGlu IHRoZWlyIG 9wZXJhdGlv bnMgdG8gY3 JlYXRlIGEg cG9zaXRpdm UgaW1wYWN0 IG9uIHRoZS BlbnZpcm9u bWVudCBhbm Qgc29jaWV0 eS4=
Interesting facts about the company
Coloplast

πŸ“ˆ Want to read more about Coloplast?

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvcE l5V3VvM2JY VkQ1T0trQm lxcGEud2Vi cCIgYWx0PS JDb2xvcGxh c3QiIHRpdG xlPSJDb2xv cGxhc3QiIC BjbGFzcz0i aW1nLWZsdW lkIiBoZWln aHQ9OTAgd2 lkdGg9OTAg bG9hZGluZz 0nbGF6eScg c3R5bGU9J2 JvcmRlci1y YWRpdXM6ID ZweDsnPgoK ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdmbGV4Oi AxOyB0ZXh0 LWFsaWduOi BjZW50ZXI7 IG1hcmdpbi 1sZWZ0OiA1 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PHAgc3R5bG U9J2ZvbnQt c2l6ZTogMj ZweDsgY29s b3I6ICMzMz M7IG1hcmdp bi1ib3R0b2 06IDE1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IPCfk4ggV2 FudCB0byBy ZWFkIG1vcm UgYWJvdXQg Q29sb3BsYX N0PwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg4pyFIE Rvd25sb2Fk IDxpPiJUaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzIj wvaT4g4oCU IHRvdGFsbH kgZnJlZSEK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9wPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxMnB4Oy Bmb250LXNp emU6IDEzcH g7IGNvbG9y OiAjNDQ0Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IG5vdyBhbm QgZ2V0IG91 ciBmcmVlIG VCb29rIAog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGI+ VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr czwvYj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IC0tPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID E2cHg7IGZv bnQtc2l6ZT ogMTRweDsg Y29sb3I6IC M0NDQ7IGZv bnQtZmFtaW x5OiAtYXBw bGUtc3lzdG VtLCBCbGlu a01hY1N5c3 RlbUZvbnQs IFNlZ29lIF VJLCBSb2Jv dG8sIEhlbH ZldGljYSBO ZXVlLCBzYW 5zLXNlcmlm OyBsaW5lLW hlaWdodDog MS42Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBIYX ZlIHlvdSBo ZWFyZCBhYm 91dCBvdXIg c2hvcnQgPH N0cm9uZyBz dHlsZT0nZm 9udC13ZWln aHQ6IDYwMD snPkRhaWx5 IFZpZGVvIE 5ld3NsZXR0 ZXI8L3N0cm 9uZz4/CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdodH RwczovL3d3 dy5pbnNpZ2 h0ZnVsdmFs dWUuY29tL2 5ld3NsZXR0 ZXIucGhwJy B0YXJnZXQ9 J19ibGFuay cgc3R5bGU9 J2NvbG9yOi AjMDA3QkZG OyB0ZXh0LW RlY29yYXRp b246IG5vbm U7IGZvbnQt d2VpZ2h0Oi A1MDA7IG1h cmdpbi1sZW Z0OiA2cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBGaW 5kIG91dCBt b3JlCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8L2E+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgCiAg ICAgICAgCi AgICAgICAg PHNwYW4gY2 xhc3M9J2Js dXJyZWQtdG V4dCc+CiAg ICAgICAgIC AgIE1TNGdR MjlzYjMgQn NZWE4wSUhk aCBjeUJtYj NWdVpHIFZr SUdsdUlERT UgTlRjZ2FX NGdSRyBWdW JXRnlheUJp IGVTQkJZV2 RsSUUgeHZk V2x6TFVoaC Bibk5sYml3 Z2QyIGh2SU hkaGN5QnQg YjNScGRtRj BaVyBRZ1lu a2dhR2x6IE lHOTNiaUJs ZUggQmxjbW xsYm1ObCBJ SGRwZEdnZ1 lXIDRnYjNO MGIyMTUgTG lBOFluSStN aSA0Z1ZHaG xJR052IGJY Qmhibm5pZ0 ogbHpJR1pw Y25OMCBJSE J5YjJSMVkz IFFnZDJGek lHRWcgY0d4 aGMzUnBZeS BCdmMzUnZi WGtnIFltRm 5MQ0IwYUcg VWc0b0NjUT I5cyBiM0Jz WVhOMElFID l6ZEc5dGVT QkMgWVdjcz RvQ2RJSCBk b2FXTm9JRU ZoIFoyVWdU RzkxYVggTX RTR0Z1YzJW dSBJR1JsYz JsbmJtIFZr SUdocGJYTm wgYkdZZ1lX NWtJRyAxaG NtdGxkR1Zr IElIUnZJR3 h2WTIgRnNJ R2h2YzNCcC BkR0ZzY3k0 Z1BHIEp5UG pNdUlGUm8g WlNCamIyMX dZVyA1NTRv Q1pjeUJ1IF lXMWxJSGRo Y3kgQmphRz l6Wlc0ZyBZ WE1nWVNCam IyIDFpYVc1 aGRHbHYgYm lCdlppQjBh RyBVZ2QyOX laSE1nIDRv Q2NRMjlzYV ggUnBjK0tB blNBbyBZU0 JqYjIxdGIy IDRnWTI5dV pHbDAgYVc5 dUlHWnZjaS BCdmMzUnZi WGtnIGNHRj BhV1Z1ZEgg TXBJR0Z1Wk NEaSBnSnh3 YkdGemRHIG xqNG9DZElD aDAgYUdVZ2 JXRjBaWCBK cFlXd2dkWE 5sIFpDQnBi aUIwYUcgVn BjaUJ3Y205 ayBkV04wY3 lrdUlEIHhp Y2o0MExpQk ogYmlBeE9U azNMQyBCRG IyeHZjR3ho IGMzUWdZbV ZqWVcgMWxJ SFJvWlNCbS BhWEp6ZENC amIyIDF3WV c1NUlHbHUg SUhSb1pTQj NiMyBKc1pD QjBieUJrIF pYWmxiRzl3 SUcgRnVJRz l6ZEc5dCBl U0JpWVdjZ2 QyIGwwYUNC aGJpQnAgYm 5SbFozSmhk RyBWa0lITn JhVzRnIFlt RnljbWxsY2 kgd2diV0Zy YVc1biBJSF JvWlNCaVlX IGNnWldGem FXVnkgSUdG dVpDQnhkVy BsamEyVnlJ SFJ2IElHTm 9ZVzVuWlMg NGdQR0p5UG pVdSBJRU52 Ykc5d2JHIE Z6ZENCM1lY TWcgYjI1bE lHOW1JSCBS b1pTQm1hWE p6IGRDQmpi MjF3WVcgNX BaWE1nZEc4 ZyBkWE5sSU VsdWMzIFJo WjNKaGJTQm 0gYjNJZ1ky OXljRyA5eV lYUmxJRzFo IGNtdGxkR2 x1Wnkgd2dj M1JoY25ScC BibWNnYVc0 Z01qIEF4TW k0Z1BHSnkg UGpZdUlGUm 9aUyBCamIy MXdZVzU1IE lHOXdaWEpo ZEcgVnpJR2 x1SUc5MiBa WElnTlRBZ1 kyIDkxYm5S eWFXVnogSU dGdVpDQm9Z WCBNZ2JXOX laU0IwIGFH RnVJREV3TE QgQXdNQ0Js YlhCcyBiM2 xsWlhNZ2Qy IDl5YkdSM2 FXUmwgTGlB OFluSStOeS A0Z1EyOXNi M0JzIFlYTj A0b0NaY3kg QmpiM0p3Yj NKaCBkR1Vn YUdWaFpIIE YxWVhKMFpY SWcgYVhNZ2 JHOWpZWCBS bFpDQnBiaU JJIGRXMXNa V0poWlcgc3 NJRVJsYm0x aCBjbXNzSU dKMWRDIEIw YUdVZ1kyOX QgY0dGdWVT Qm9ZWCBNZ1 ptRmphV3hw IGRHbGxjeU JoYm0gUWdi MlptYVdObC BjeUJwYmlC amIzIFZ1ZE hKcFpYTWcg WVhKdmRXNW tJSCBSb1pT QjNiM0pzIF pDd2dhVzVq YkggVmthVz VuSUhSbyBa U0JWYm1sMF pXIFFnVTNS aGRHVnogTE NCRFlXNWha RyBFc0lFTm 9hVzVoIExD QmhibVFnVT IgOTFkR2dn UVdaeSBhV0 5oTGlBOFlu IEkrT0M0Z1 NXNGcgTWpB eU1Dd2dSbS A5eVltVnpJ RzVoIGJXVm tJRU52Ykcg OXdiR0Z6ZE NCaCBjeUJ2 Ym1VZ2IyIF lnZEdobElI ZHYgY214az RvQ1pjeSBC dGIzTjBJR2 x1IGJtOTJZ WFJwZG0gVW dZMjl0Y0dG dSBhV1Z6TG lBOFluIEkr T1M0Z1EyOX MgYjNCc1lY TjBJRyBsek lHRWdiR1Zo IFpHVnlJR2 x1SUcgUmxk bVZzYjNCcC BibWNnYjNO MGIyIDE1TE NCMWNtOXMg YjJkNUxDQm piMiA1MGFX NWxibU5sIE xDQmhibVFn ZDIgOTFibV FnWTJGeSBa U0J3Y205a2 RXIE4wY3l3 Z1luVjAgSU hSb1pTQmpi MiAxd1lXNT VJR0ZzIGMy OGdiMlptWl ggSnpJSEJ5 YjJSMSBZM1 J6SUdsdUlH IDkwYUdWeU lHRnkgWldG eklITjFZMi BnZ1lYTWdj MnRwIGJpQm 9aV0ZzZEcg Z2dZVzVrSU dsdSBkR1Z5 ZG1WdWRHIG x2Ym1Gc0lI VnkgYjJ4dl oza3VJRCB4 aWNqNHhNQz RnIFNXNGdZ V1JrYVggUn BiMjRnZEc4 ZyBiV1ZrYV dOaGJDIEJ3 Y205a2RXTj AgY3l3Z1Ey OXNiMyBCc1 lYTjBJR0Zz IGMyOGdiMl ptWlggSnpJ SE4xY0hCdi BjblFnYzJW eWRtIGxqWl hNZ1ptOXkg SUc5emRHOX RlUyBCd1lY UnBaVzUwIG N5d2dhVzVq YkggVmthVz VuSUdGdSBJ Rzl1YkdsdV pTIEJqYjIx dGRXNXAgZE hrZ1lXNWtJ RyBFZ2JXOW lhV3hsIElH RndjQ0JtYj MgSWdkSEpo WTJ0cCBibW NnWVc1a0lH IDFoYm1Gbm FXNW4gSUc5 emRHOXRlUy BCemRYQndi R2xsIGN5ND 0KICAgICAg ICA8L3NwYW 4+CiAgICAg ICAgCiAgIC AgICAg
See Company Q&A
Coloplast

πŸ“Š Get full analytics about Coloplast

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal